Home Cart 0 Sign in  
X

[ CAS No. 36052-24-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 36052-24-1
Chemical Structure| 36052-24-1
Chemical Structure| 36052-24-1
Structure of 36052-24-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 36052-24-1 ]

Related Doc. of [ 36052-24-1 ]

Alternatived Products of [ 36052-24-1 ]

Product Details of [ 36052-24-1 ]

CAS No. :36052-24-1 MDL No. :MFCD00797844
Formula : C7H8N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :JACPDLJUQLKABC-UHFFFAOYSA-N
M.W : 152.15 Pubchem ID :737487
Synonyms :

Calculated chemistry of [ 36052-24-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 39.92
TPSA : 65.21 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.04 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.44
Log Po/w (XLOGP3) : 1.68
Log Po/w (WLOGP) : 0.46
Log Po/w (MLOGP) : 0.15
Log Po/w (SILICOS-IT) : 0.47
Consensus Log Po/w : 0.84

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.11
Solubility : 1.17 mg/ml ; 0.0077 mol/l
Class : Soluble
Log S (Ali) : -2.66
Solubility : 0.33 mg/ml ; 0.00217 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.73
Solubility : 2.87 mg/ml ; 0.0188 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.54

Safety of [ 36052-24-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 36052-24-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 36052-24-1 ]
  • Downstream synthetic route of [ 36052-24-1 ]

[ 36052-24-1 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 36052-24-1 ]
  • [ 329-89-5 ]
Reference: [1] Bollettino Chimico Farmaceutico, 1957, vol. 96, p. 542,543
  • 2
  • [ 67-56-1 ]
  • [ 3167-49-5 ]
  • [ 36052-24-1 ]
YieldReaction ConditionsOperation in experiment
89% at 80℃; for 12 h; Inert atmosphere General procedure: A mixture of 4-aminobenzoic acid (32-34, 5.0 mmol), thionyl chloride(1.487 g, 5.0 mmol), and MeOH (20.0 mL) was flushed with argon, and stirred at80°C for 12 hours. Remove reaction solvent by rota vapor. The reaction mixture wasneutralized with NaHCO3(sat) (20.0 mL) and extracted with ethyl acetate (100 mL ×3). The combined organic extracts were washed with brine, dried by Na2SO4, filtered,and evaporated, to get cmopound 35-37 (63-89percent) as a white solid.
81.5% at 0 - 80℃; To a stirred solution of 6-amino-nicotinic acid (25 g, 181.1 mmol) in MeOH (200 mL) is added concentrated H2504 (7 mL) at 0 °C and the reaction mixture is heated at 80°C for overnight. The reaction mixture is cooled to room temperature and neutralized with saturated NaHCO3 solution (100 mL). The precipitated solid is filtered and dried under vacuum to give the title compound as a yellow solid (22 g, 8 1.5percent). LCMS mlz 153(M+H)t
81.5% at 0 - 80℃; To a stirred solution of 6-amino-nicotinic acid (25 g, 181.1 mmol) in MeOH (200 mL) is added concentrated H2SO4 (7 mL) at 0 ° C. and the reaction mixture is heated at 80 ° C. for overnight.
The reaction mixture is cooled to room temperature and neutralized with saturated NaHCO3 solution (100 mL).
The precipitated solid is filtered and dried under vacuum to give the title compound as a yellow solid (22 g, 81.5percent). LCMS m/z 153 (M+H)+.
72% at 0 - 80℃; for 16 h; PREPARATION 1
Methyl 6-aminopyridine-3-carboxylate
To a solution of 6-aminopyridine 3-carboxylic acid (30 g, 217.1 mmol) in methanol (30 mL) is added H2SO4 (30 mL at 0° C.) and the reaction mixture is heated to 80° C. for 16 hours.
The reaction mixture is evaporated and the residue is neutralized with aqueous NaHCO3 solution (50 mL), the precipitated solid is filtered and dried to give the title compound as a pale yellow solid (24 g, 72percent). LCMS m/z 153 (M+H)+.
71% for 16 h; Heating / reflux [0198] A mixture of 6-aminonicotinic acid (4.0 g, 28.9 mmol), methanol (75 mL), and concentrated hydrochloric acid (4 mL) was heated under reflux for 16 h. The reaction mixture was allowed to cool to 25° C. and then concentrated in vacuo to remove methanol. The resulting solid was treated with water (20 mL) and enough sodium bicarbonate to adjust the pH to pH=8. The solution was then extracted with ethyl acetate (3.x.25 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to afford 6-aminonicotinic acid methyl ester (3.12 g, 71percent) as white foam: EI-HRMS m/e calcd for C7H8N2O2 (M+) 152.0586, found 152.0586. [0199] A solution of 2-(4-methylsulfonyl-3-trifluoromethyl-phenyl)-3-(tetrahydro-pyran-2-yl)-propionic acid (prepared as in Example 12, 300 mg, 0.79 mmol) in methylene chloride (6 mL) was treated with N,N-dimethylformamide (7 drops) and then cooled to 0° C. The reaction mixture was then treated with a 2.0M solution of oxalyl chloride in methylene chloride (0.48 mL, 0.95 mmol). The reaction mixture was stirred at 0° C. for 30 min, allowed to warm to 25° C., and then concentrated in vacuo to remove solvents and excess oxalyl chloride. The resulting residue was re-dissolved in dry tetrahydrofuran (6 mL) and was treated dropwise with a solution of 6-aminonicotinic acid methyl ester (252 mg, 1.67 mmol) in tetrahydrofuran (5 mL) and 2,6-lutidine (0.48 mL, 3.95 mmol). The resulting reaction mixture was stirred at 25° C. for 16 h. The reaction mixture was then diluted with water (100 mL) and extracted with methylene chloride (3.x.50 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. Biotage chromatography (FLASH 40S, Silica, 7/3 hexanes/ethyl acetate to 1/1 hexanes/ethyl acetate) afforded 6-[2-(4-methylsulfonyl-3-trifluoromethyl-phenyl)-3-(tetrahydro-pyran-2-yl)-propionylamino]-nicotinic acid methyl ester (227 mg, 55percent) as a white foam: EI-HRMS m/e calcd for C23H25F3N2O6S (M+H)+ 537.1277 found 537.1284.
64%
Stage #1: With sulfuric acid In water for 24 h; Heating / reflux
Stage #2: With sodium hydrogencarbonate In water
Example 2: Scheme Al11 6A mixture of 6-aminonicotinic acid (1.0 equiv., 7.24 mmol, 1.00 g) and sulfuric acid (6.00 equiv., 65.16 mmol, 6.39 g) in methanol was refluxed for 24 h. After cooling to room temperature, the reaction mixture was concentrated under reduced pressure and then made alkaline by the addition of a saturated aqueous NaHCO3 solution. The aqueous layer was extracted with ethyl acetate, the combined organic layers were dried with MgSO4 and concentrated in vacuo to give methyl 6-amino-pyridine-3-carboxylate (15) (0.70 g, yield = 64percent) as a white crystalline product.
60% at 0 - 20℃; for 16 h; Inert atmosphere Methyl-6-amineonicotinate 6-Amineonicotinic acid ( 1 .00 g, 7.246 mmol, 1 .00 eq) was dissolved in abs. MeOH (40 ml) and cooled to 0 °C. SOCI2 (2.587 g, 1 .70 ml, 21 .739 mmol, 3.00 eq) was added and the reaction mixture was allowed to warm up to room temperature. After stirring for 16 h the solvent was evaporated to give the product as a pale yellow solid (60 percent). H-NMR (400 MHz, DMSO-d6): 3.75 (s, 3H), 6.43 - 6.46 (dd, Ji = 8.7 Hz, J2 = 0.7 Hz, 1 H), 6.84 (s, 2H), 7.81 - 7.83 (dd, Ji = 8.9 Hz, J2 = 2.4 Hz, 1 H), 8.50 (d, J = 2.1 Hz, 1 H), 3C-NMR (100.6 MHz, DMSO-d6): 51 .36, 107.13, 1 13.19, 137.60, 151 .04, 162.52, 165.72 HR-MS: calc.: [M+H]+ 153.0659 found: [M+H]+ 153.0654

Reference: [1] Organic Letters, 2018, vol. 20, # 15, p. 4393 - 4396
[2] European Journal of Medicinal Chemistry, 2017, vol. 140, p. 42 - 51
[3] Patent: WO2015/105779, 2015, A1, . Location in patent: Page/Page column 11
[4] Patent: US2016/333005, 2016, A1, . Location in patent: Paragraph 0041
[5] Patent: US2015/166535, 2015, A1, . Location in patent: Paragraph 0039; 0040
[6] Patent: US2003/225283, 2003, A1, . Location in patent: Page 23
[7] Patent: WO2007/113290, 2007, A1, . Location in patent: Page/Page column 27
[8] Patent: WO2014/125075, 2014, A1, . Location in patent: Page/Page column 406
[9] Patent: EP1479680, 2004, A1, . Location in patent: Page 47
[10] Patent: US2009/203705, 2009, A1, . Location in patent: Page/Page column 46
  • 3
  • [ 3167-49-5 ]
  • [ 18107-18-1 ]
  • [ 36052-24-1 ]
YieldReaction ConditionsOperation in experiment
66% at 20℃; for 1 h; 24.6 ml (3.4 equivalents) of 2.0M trimethylsilyldiazomethane in solution in cyclohexane are added to a solution of 2.0 g of 6-aminonicotinic acid in a chloroform/methanol (v/v: 10/30) mixture. The reaction medium is stirred at ambient temperature for 1 hour and is then hydrolysed with 100 μl of acetic acid and concentrated under reduced pressure. The crude product is triturated in a cyclohexane/ethyl acetate (1/2) mixture and filtered to produce 1.459 g of a yellow powder corresponding to the expected product. Yield: 66percent MS: MH+ 153
Reference: [1] Patent: US2004/72871, 2004, A1, . Location in patent: Page/Page column 17
[2] Patent: EP900207, 2001, B1,
  • 4
  • [ 3167-49-5 ]
  • [ 36052-24-1 ]
Reference: [1] Patent: US6358971, 2002, B1,
[2] Patent: US6486183, 2002, B1,
[3] Patent: US5175166, 1992, A,
  • 5
  • [ 3167-49-5 ]
  • [ 36052-24-1 ]
Reference: [1] Patent: US5536718, 1996, A,
[2] Patent: US5654297, 1997, A,
[3] Patent: US5719278, 1998, A,
[4] Patent: US5753648, 1998, A,
[5] Patent: US5700796, 1997, A,
[6] Patent: US5849735, 1998, A,
  • 6
  • [ 3167-49-5 ]
  • [ 36052-24-1 ]
Reference: [1] Patent: US5532235, 1996, A,
  • 7
  • [ 3167-49-5 ]
  • [ 7664-93-9 ]
  • [ 36052-24-1 ]
Reference: [1] Patent: US5834468, 1998, A,
  • 8
  • [ 21550-48-1 ]
  • [ 36052-24-1 ]
Reference: [1] Bollettino Chimico Farmaceutico, 1957, vol. 96, p. 542,543
  • 9
  • [ 1603-41-4 ]
  • [ 36052-24-1 ]
Reference: [1] Bollettino Chimico Farmaceutico, 1957, vol. 96, p. 542,543
  • 10
  • [ 4931-47-9 ]
  • [ 36052-24-1 ]
Reference: [1] Bollettino Chimico Farmaceutico, 1957, vol. 96, p. 542,543
  • 11
  • [ 36052-24-1 ]
  • [ 113293-71-3 ]
YieldReaction ConditionsOperation in experiment
67%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran
Stage #2: With methanol In tetrahydrofuran at 0℃;
Compound 15 (1.0 equiv., 3.94 mmol, 0.600 g) was added portion wise to a suspension OfLiAlH4 (3.00 equiv., 11.83 mmol, 0.449 g) in dry THF (17 ml) at 00C. The reaction mixture was stirred at room temperature overnight. Excess LiAlH4 was destroyed by addition of methanol (while cooling on ice), the reaction mixture was filtered over Celite and the filtrate concentrated under reduced pressure. The crude product was purified by column chromatography (dichloromethane / methanol 75:25) to give 6-amino-3-pyridinemethanol (16) (0.330 g, yield = 67percent) as a white solid. 1H NMR (δ, CD3OD): 4.43 (2H, s), 6.58 (IH, d, J = 8.5 Hz), 7.48 (IH, dd, J = 8.5, ~ 2 Hz) 7.86 (IH, d, J ~ 2 Hz)
Reference: [1] Patent: WO2007/113290, 2007, A1, . Location in patent: Page/Page column 28
  • 12
  • [ 36052-24-1 ]
  • [ 132213-07-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 21, p. 6586 - 6590
  • 13
  • [ 36052-24-1 ]
  • [ 106730-54-5 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1991, vol. 39, # 6, p. 1556 - 1567
  • 14
  • [ 36052-24-1 ]
  • [ 169280-83-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1998, vol. 41, # 4, p. 602 - 617
  • 15
  • [ 36052-24-1 ]
  • [ 139022-25-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 3, p. 465 - 469
  • 16
  • [ 36052-24-1 ]
  • [ 231958-14-8 ]
Reference: [1] Patent: WO2010/144345, 2010, A1,
[2] Patent: WO2016/33445, 2016, A1,
[3] Patent: WO2010/130708, 2010, A1,
  • 17
  • [ 36052-24-1 ]
  • [ 849067-96-5 ]
Reference: [1] Patent: US2011/144105, 2011, A1,
  • 18
  • [ 36052-24-1 ]
  • [ 1313725-89-1 ]
  • [ 1313725-88-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 18, p. 7577 - 7589
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 36052-24-1 ]

Esters

Chemical Structure| 39658-41-8

[ 39658-41-8 ]

Ethyl 6-aminonicotinate

Similarity: 0.97

Chemical Structure| 93-60-7

[ 93-60-7 ]

3-(Methoxycarbonyl)pyridine

Similarity: 0.85

Chemical Structure| 1260791-59-0

[ 1260791-59-0 ]

Methyl 5-(aminomethyl)nicotinate hydrochloride

Similarity: 0.85

Chemical Structure| 1260663-92-0

[ 1260663-92-0 ]

Methyl 6-amino-5-hydroxynicotinate

Similarity: 0.85

Chemical Structure| 33402-75-4

[ 33402-75-4 ]

Methyl 4-methylnicotinate

Similarity: 0.83

Amines

Chemical Structure| 39658-41-8

[ 39658-41-8 ]

Ethyl 6-aminonicotinate

Similarity: 0.97

Chemical Structure| 179555-11-4

[ 179555-11-4 ]

6-Amino-4-methylnicotinic acid

Similarity: 0.89

Chemical Structure| 133081-24-0

[ 133081-24-0 ]

6-Hydrazinylnicotinic acid

Similarity: 0.85

Chemical Structure| 1260791-59-0

[ 1260791-59-0 ]

Methyl 5-(aminomethyl)nicotinate hydrochloride

Similarity: 0.85

Chemical Structure| 1260663-92-0

[ 1260663-92-0 ]

Methyl 6-amino-5-hydroxynicotinate

Similarity: 0.85

Related Parent Nucleus of
[ 36052-24-1 ]

Pyridines

Chemical Structure| 39658-41-8

[ 39658-41-8 ]

Ethyl 6-aminonicotinate

Similarity: 0.97

Chemical Structure| 179555-11-4

[ 179555-11-4 ]

6-Amino-4-methylnicotinic acid

Similarity: 0.89

Chemical Structure| 93-60-7

[ 93-60-7 ]

3-(Methoxycarbonyl)pyridine

Similarity: 0.85

Chemical Structure| 133081-24-0

[ 133081-24-0 ]

6-Hydrazinylnicotinic acid

Similarity: 0.85

Chemical Structure| 1260791-59-0

[ 1260791-59-0 ]

Methyl 5-(aminomethyl)nicotinate hydrochloride

Similarity: 0.85